Suchergebnisse - "Bestvina, Christine M."

PubPharm (38)

1

Evaluation of Major Pathologic Response and Pathologic Complete Response as Surrogate End Points for Survival in Randomized Controlled Trials of Neoadjuvant Immune Checkpoint Blockade in Resectable in NSCLC

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von Hines, J. | Cameron, R. | Esposito, A. | +16

2

Combined Stereotactic Body Radiation Therapy and Immune Checkpoint Inhibition for Liver Metastases : Safety and Outcomes in a Pooled Analysis of 3 Phase 1 Trials

enthalten in: International journal of radiation oncology, biology, physics | 2024

von Lynch, C. | Korpics, M. | Katipally, R. | +5

3

A Phase 1/2 Study to Evaluate the Safety and Activity of Nivolumab in Combination With Vorolanib, a Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitor, in Patients With Refractory Thoracic Tumors

enthalten in: JTO clinical and research reports | 2024

von Beckermann, K. | Bestvina, C. | El Osta, B. | +11

4

Cost of genetic testing, delayed care, and suboptimal treatment associated with polymerase chain reaction versus next-generation sequencing biomarker testing for genomic alterations in metastatic non-small cell lung cancer

enthalten in: Journal of medical economics | 2024

von Bestvina, C. | Waters, D. | Morrison, L. | +6

5

Sotorasib with panitumumab in chemotherapy-refractory KRASG12C-mutated colorectal cancer : a phase 1b trial

enthalten in: Nature medicine | 2024

von Kuboki, Y. | Fakih, M. | Strickler, J. | +16

6

Disparities in outcomes between Black and White patients in North America with thoracic malignancies and COVID-19 infection (TERAVOLT)

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2023

von Burns, L. | Hsu, C. | Whisenant, J. | +26

7

Abnormalities on baseline chest imaging are risk factors for immune checkpoint inhibitor associated pneumonitis

enthalten in: Respiratory medicine | 2023

von Stahlbaum, D. | Jablonski, R. | Strek, M. | +3

8

Early-Stage Lung Cancer : Using Circulating Tumor DNA to Get Personal

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Bestvina, C. | Garassino, M. | Neal, J. | +3

9

Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC

enthalten in: Cancer discovery | 2023

von Negrao, M. | Araujo, H. | Lamberti, G. | +63

CommentIn: Cancer Discov. 2023 Jul 7;13(7):1513-1515. - PMID 37416990

10

The Role of MET in Resistance to EGFR Inhibition in NSCLC : A Review of Mechanisms and Treatment Implications

enthalten in: Cancers | 2023

von Feldt, S. | Bestvina, C.